We provide you with 20 years of free, institutional-grade data for MDGL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MDGL. Explore the full financial landscape of MDGL stock.
Total insider purchase within 3 month on this page: $58,631,154
Total insider selling within 3 month on this page: -$110,846,463
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Sibold William John | Sale | -7,279 | $445.63 | $3,243,741 | 2025-09-09 |
| Sibold William John | Sale | -7,616 | $400.03 | $3,046,664 | 2025-08-21 |
| BAKER BROS. ADVISORS LP | Open Market Purchase | 151,707 | $353.88 | 2025-08-20 | |
| BAKER BROS. ADVISORS LP | Open Market Purchase | 13,976 | $353.88 | 2025-08-20 | |
| Kelley Shannon T | Sale | -1,304 | $358.66 | $467,693 | 2025-08-18 |
| BATE KENNETH | Sale | -10,000 | $363.41 | $3,634,072 | 2025-08-15 |
| BATE KENNETH | Derivatives Exercise | 10,000 | 2025-08-15 | ||
| Taub Rebecca | Sale | -46,463 | $350.18 | $16,270,288 | 2025-08-13 |
| Taub Rebecca | Derivatives Exercise | 46,463 | 2025-08-13 | ||
| FRIEDMAN PAUL A | Sale | -175,980 | $358.23 | $63,041,650 | 2025-08-13 |
| FRIEDMAN PAUL A | Derivatives Exercise | 175,980 | 2025-08-13 | ||
| Brennan Daniel J. | Grant, award...etc | 967 | 2025-08-05 | ||
| Taub Rebecca | Sale | -1,000 | $350 | $350,005 | 2025-07-22 |
| Taub Rebecca | Derivatives Exercise | 1,000 | 2025-07-22 | ||
| FRIEDMAN PAUL A | Sale | -1,400 | $350.03 | $490,044 | 2025-07-22 |
| FRIEDMAN PAUL A | Derivatives Exercise | 1,400 | 2025-07-22 | ||
| FRIEDMAN PAUL A | Sale | -28,876 | $350.17 | $10,111,419 | 2025-07-18 |
| FRIEDMAN PAUL A | Derivatives Exercise | 28,876 | 2025-07-18 | ||
| Taub Rebecca | Sale | -29,101 | $350.19 | $10,190,888 | 2025-07-18 |
| Taub Rebecca | Derivatives Exercise | 29,101 | 2025-07-18 | ||
| Daly James M | Grant, award...etc | 715 | 2025-06-24 | ||
| FRIEDMAN PAUL A | Grant, award...etc | 715 | 2025-06-24 | ||
| Levy Richard S | Grant, award...etc | 715 | 2025-06-24 | ||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 1,430 | 2025-06-24 | ||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 1,430 | 2025-06-24 | ||
| FOUSE JACQUALYN A | Grant, award...etc | 203 | 2025-06-24 | ||
| BATE KENNETH | Grant, award...etc | 715 | 2025-06-24 | ||
| Soergel David | Grant, award...etc | 7,545 | 2025-05-16 | ||
| Levy Richard S | Derivatives Exercise | 9,470 | 2025-04-11 | ||
| CRAVES FRED B | Sale | -15,470 | $330.54 | $5,113,386 | 2025-03-14 |
| CRAVES FRED B | Derivatives Exercise | 15,470 | 2025-03-14 | ||
| FOUSE JACQUALYN A | Grant, award...etc | 894 | 2025-03-12 | ||
| Dier Mardi | Sale | -258 | $323.04 | $83,344 | 2025-03-12 |
| Kelley Shannon T | Grant, award...etc | 3,187 | 2025-03-07 | ||
| Huntsman Carole | Grant, award...etc | 3,386 | 2025-03-07 | ||
| Dier Mardi | Grant, award...etc | 3,784 | 2025-03-07 | ||
| Sibold William John | Grant, award...etc | 13,066 | 2025-03-07 | ||
| Taub Rebecca | Grant, award...etc | 4,382 | 2025-03-07 | ||
| Waltermire Robert E. | Grant, award...etc | 2,061 | 2025-03-07 | ||
| Waltermire Robert E. | Sale | -14,113 | $335.15 | $4,729,914 | 2025-03-07 |
| Waltermire Robert E. | Derivatives Exercise | 14,113 | 2025-03-07 | ||
| Dier Mardi | Sale | -1,961 | $325.89 | $639,070 | 2025-03-05 |
| Kelley Shannon T | Sale | -415 | $335 | $139,025 | 2025-03-05 |
| Huntsman Carole | Sale | -1,834 | $313.08 | $574,189 | 2025-03-05 |
| Waltermire Robert E. | Sale | -1,227 | $340.99 | $418,389 | 2025-03-04 |
| Sibold William John | Derivatives Exercise | 50,000 | 2025-02-28 | ||
| Daly James M | Sale | -15,470 | $346.9 | $5,366,591 | 2025-02-28 |
| Daly James M | Derivatives Exercise | 15,470 | 2025-02-28 | ||
| BATE KENNETH | Sale | -20,000 | $351.01 | $7,020,146 | 2025-02-28 |
| BATE KENNETH | Derivatives Exercise | 20,000 | 2025-02-28 | ||
| Taub Rebecca | Sale | -648 | $335.24 | $217,236 | 2025-01-27 |
| Sibold William John | Sale | -1,584 | $335.24 | $531,020 | 2025-01-27 |
| Waltermire Robert E. | Sale | -103 | $335.24 | $34,530 | 2025-01-27 |
| Huntsman Carole | Sale | -347 | $335.24 | $116,328 | 2025-01-27 |
| Taub Rebecca | Sale | -1,689 | $273.41 | $461,789 | 2025-01-17 |
| Waltermire Robert E. | Sale | -442 | $273.41 | $120,847 | 2025-01-17 |
| Kelley Shannon T | Sale | -277 | $273.41 | $75,735 | 2025-01-17 |
| CRAVES FRED B | Sale | -3,600 | $315.21 | $1,134,762 | 2024-12-05 |
| CRAVES FRED B | Sale | -3,400 | $350.08 | $1,190,264 | 2024-11-27 |
| Huntsman Carole | Sale | -688 | $316.92 | $218,041 | 2024-11-22 |
| Levy Richard S | Sale | -5,000 | $350 | $1,750,000 | 2024-11-08 |
| Levy Richard S | Derivatives Exercise | 5,000 | 2024-11-08 | ||
| Levy Richard S | Sale | -5,000 | $300.1 | $1,500,497 | 2024-11-05 |
| Levy Richard S | Derivatives Exercise | 5,000 | 2024-11-05 | ||
| Sibold William John | Sale | -6,363 | $243.83 | $1,551,490 | 2024-09-11 |
| Kelley Shannon T | Grant, award...etc | 5,215 | 2024-08-19 | ||
| Kelley Shannon T | Initial | 2024-08-15 | |||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 1,428 | 2024-06-27 | ||
| BAKER BROS. ADVISORS LP | Grant, award...etc | 1,428 | 2024-06-27 | ||
| FRIEDMAN PAUL A | Grant, award...etc | 714 | 2024-06-27 | ||
| Daly James M | Grant, award...etc | 714 | 2024-06-27 | ||
| BATE KENNETH | Grant, award...etc | 714 | 2024-06-27 | ||
| CRAVES FRED B | Grant, award...etc | 714 | 2024-06-27 | ||
| Levy Richard S | Grant, award...etc | 714 | 2024-06-27 | ||
| Waltermire Robert E. | Sale | -1,900 | $280 | $532,000 | 2024-06-18 |
| Waltermire Robert E. | Derivatives Exercise | 1,900 | 2024-06-18 | ||
| Waltermire Robert E. | Sale | -2,000 | $285 | $570,000 | 2024-06-14 |
| Waltermire Robert E. | Derivatives Exercise | 2,000 | 2024-06-14 | ||
| Waltermire Robert E. | Sale | -1,036 | $231.34 | $239,668 | 2024-05-23 |
| CRAVES FRED B | Sale | -22,489 | $210.99 | $4,745,013 | 2024-05-16 |
| CRAVES FRED B | Derivatives Exercise | 22,489 | 2024-05-16 | ||
| Taub Rebecca | Sale | -2,676 | $243.25 | $650,924 | 2024-04-10 |
| Taub Rebecca | Derivatives Exercise | 2,676 | 2024-04-10 | ||
| FRIEDMAN PAUL A | Sale | -26,270 | $242.95 | $6,382,357 | 2024-04-10 |
| FRIEDMAN PAUL A | Derivatives Exercise | 26,270 | 2024-04-10 | ||
| Taub Rebecca | Sale | -73,888 | $242 | $17,880,896 | 2024-04-05 |
| Taub Rebecca | Derivatives Exercise | 73,888 | 2024-04-05 | ||
| FRIEDMAN PAUL A | Sale | -73,730 | $242 | $17,842,660 | 2024-04-05 |
| FRIEDMAN PAUL A | Derivatives Exercise | 73,730 | 2024-04-05 | ||
| Daly James M | Sale | -32,489 | $255.64 | $8,305,377 | 2024-04-03 |
| Daly James M | Derivatives Exercise | 32,489 | 2024-04-03 | ||
| BATE KENNETH | Sale | -32,489 | $255.62 | $8,304,724 | 2024-04-03 |
| BATE KENNETH | Derivatives Exercise | 32,489 | 2024-04-03 | ||
| Levy Richard S | Sale | -11,000 | $255.9 | $2,814,889 | 2024-04-03 |
| Levy Richard S | Derivatives Exercise | 11,000 | 2024-04-03 | ||
| BAKER BROS. ADVISORS LP | Open Market Purchase | 1,057,692 | $260 | 2024-03-25 | |
| Dier Mardi | Initial | 2024-03-21 | |||
| Lynch Brian Joseph | Grant, award...etc | 3,639 | 2024-01-25 | ||
| Howarth Alex G. | Grant, award...etc | 4,803 | 2024-01-25 | ||
| Sibold William John | Grant, award...etc | 12,250 | 2024-01-25 | ||
| Taub Rebecca | Grant, award...etc | 5,786 | 2024-01-25 | ||
| Waltermire Robert E. | Grant, award...etc | 1,419 | 2024-01-25 | ||
| Huntsman Carole | Grant, award...etc | 3,639 | 2024-01-25 | ||
| Howarth Alex G. | Sale | -1,067 | $243.92 | $260,263 | 2024-01-18 |
| Waltermire Robert E. | Sale | -550 | $243.92 | $134,156 | 2024-01-18 |
| Taub Rebecca | Sale | -1,546 | $243.92 | $377,100 | 2024-01-18 |
| FRIEDMAN PAUL A | Sale | -2,254 | $243.92 | $549,796 | 2024-01-18 |
| Lynch Brian Joseph | Sale | -949 | $243.92 | $231,480 | 2024-01-18 |
| Waltermire Robert E. | Sale | -4,000 | $233 | $932,000 | 2023-12-18 |
| Waltermire Robert E. | Derivatives Exercise | 4,000 | 2023-12-18 |
The information provided in this report about MDGL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Madrigal Pharmaceuticals, Inc(NASDAQ:MDGL) 
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormon...
Website: http://www.madrigalpharma.com
Founded: 2011
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology